Literature DB >> 15679763

Functional symptoms in inflammatory bowel disease and their potential influence in misclassification of clinical status.

H S Barratt1, C Kalantzis, D Polymeros, A Forbes.   

Abstract

BACKGROUND: Functional symptoms occur in inflammatory bowel disease probably more than in the general population. Existing disease indices rely heavily on symptoms that may be organic or functional. This may explain inconsistencies between recent therapeutic trials in inflammatory bowel disease. Clinically, misinterpretation can lead to over-treatment of functional symptoms with potent agents, and to under-treatment of inflammatory bowel disease when inflammatory features are more subtle. AIM: To assess functional symptoms in inflammatory bowel disease and to devise simple means of their evaluation.
METHODS: Patients with Crohn's disease, ulcerative colitis, and irritable bowel syndrome completed questionnaires, generating inflammatory bowel disease and irritable bowel syndrome indices. Data from outliers selected as exemplars were employed to create a new index.
RESULTS: One hundred and ninety patients completed questionnaires. Overall, Crohn's and irritable bowel syndrome patients had similar functional features. The new scoring system was based on the eight apparently discriminant symptoms. Prospective evaluation in a separate cohort of 180 inflammatory bowel disease patients yielded scores that are independent of established indices, inflammatory markers and psychometric scores.
CONCLUSIONS: Patients with Crohn's report comparable rates of apparently functional symptoms to those with irritable bowel syndrome. A new score has been developed to help in their identification. This has the potential to guide therapeutic decisions and optimize future trial recruitment.

Entities:  

Mesh:

Year:  2005        PMID: 15679763     DOI: 10.1111/j.1365-2036.2005.02314.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  7 in total

Review 1.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

Review 2.  Diagnosis and management of functional symptoms in inflammatory bowel disease in remission.

Authors:  Carlos Teruel; Elena Garrido; Francisco Mesonero
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-02-06

3.  Irritable Bowel Syndrome on Inflammatory Bowel Disease in Deep Remission: No Relation with Remission Deepening and Inflammation.

Authors:  Orhan Sezgin; Burcu Boztepe; Enver Üçbilek; Engin Altintas; Havva Didem Celikcan
Journal:  Turk J Gastroenterol       Date:  2021-10       Impact factor: 1.852

4.  Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression.

Authors:  Lilani P Perera; Mark Radigan; Corinne Guilday; Indrani Banerjee; Daniel Eastwood; Reji Babygirija; Benson T Massey
Journal:  Dig Dis Sci       Date:  2019-02-06       Impact factor: 3.487

Review 5.  Bile Acid-Related Regulation of Mucosal Inflammation and Intestinal Motility: From Pathogenesis to Therapeutic Application in IBD and Microscopic Colitis.

Authors:  Federica Di Vincenzo; Pierluigi Puca; Loris Riccardo Lopetuso; Valentina Petito; Letizia Masi; Bianca Bartocci; Marco Murgiano; Margherita De Felice; Lorenzo Petronio; Antonio Gasbarrini; Franco Scaldaferri
Journal:  Nutrients       Date:  2022-06-27       Impact factor: 6.706

6.  "It doesn't do any harm, but patients feel better": a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease.

Authors:  Antonina A Mikocka-Walus; Deborah A Turnbull; Nicole T Moulding; Ian G Wilson; Jane M Andrews; Gerald J Holtmann
Journal:  BMC Gastroenterol       Date:  2007-09-24       Impact factor: 3.067

7.  Psychological problems in gastroenterology outpatients: A South Australian experience. Psychological co-morbidity in IBD, IBS and hepatitis C.

Authors:  Antonina A Mikocka-Walus; Deborah A Turnbull; Jane M Andrews; Nicole T Moulding; Ian G Wilson; Hugh Aj Harley; David J Hetzel; Gerald J Holtmann
Journal:  Clin Pract Epidemiol Ment Health       Date:  2008-05-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.